PMID: 8603009Feb 1, 1996Paper

Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM)

British Journal of Haematology
M C KyrstsonisA Maniatis

Abstract

In this study we determined, in patients with multiple myeloma (MM), serum levels of IL-4 and IL-6 at diagnosis and during the course of the disease, seeking a correlation with disease activity and prognosis. We studied 54 MM patients, 41 of whom responded to chemotherapy whilst 11 were resistant. At diagnosis, IL-6 was increased in 66% of patients (median 35.5 pg/ml) whereas IL-4 was low (median 4 pg/ml) in 75% of patients. In responding patients, IL-4 increased in remission (median 25 pg/ml), whereas IL-6 decreased (median 4 pg/ml). In chemotherapy-resistant patients, IL-6 and IL-4 values remained stable during the course of the disease.

Citations

May 19, 2000·Cell Biology International·K GadóA Falus
Aug 24, 1999·Medical Oncology·M C KyrtsonisA Maniatis
Aug 7, 2002·Blood Reviews·Joan J RyooKenneth C Anderson
Oct 16, 1999·British Journal of Haematology·C G SchaarJ C Kluin-Nelemans
May 8, 1999·British Journal of Haematology·A WierzbowskaT Robak
Dec 12, 2013·Seminars in Immunology·Jürgen SchellerStefan Rose-John
Apr 7, 2010·Leukemia & Lymphoma·Alpana SharmaManoj Sharma
Feb 27, 1999·Leukemia & Lymphoma·C MathiotC Sautès
Jun 7, 2005·Expert Opinion on Therapeutic Targets·Klaus PodarKenneth C Anderson
Jun 14, 2013·Cancer Investigation·Constantina A PappaMichael G Alexandrakis
Nov 25, 2003·British Journal of Haematology·Evangelos TerposAmin Rahemtulla
Jul 20, 2005·Best Practice & Research. Clinical Haematology·Teru HideshimaKenneth C Anderson
Feb 1, 1997·Hematology/oncology Clinics of North America·M Boccadoro, A Pileri
Apr 1, 1997·The Journal of Surgical Research·A A HavertyD J Bouchier-Hayes
Jun 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Terpos, M-A Dimopoulos
Dec 13, 2003·Endocrine Reviews·Bellur S PrabhakarTerry J Smith
Aug 1, 2009·Expert Review of Hematology·Dimitrios ChristoulasMeletios A Dimopoulos
Aug 30, 2002·Blood·Dharminder ChauhanKenneth C Anderson
Sep 25, 2017·European Journal of Cancer Care·E TerposM A Dimopoulos
Jun 19, 2021·Cancer Investigation·Chunjue YuanYong Ning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.